Gina Stephen
Pediatrics · Houston, TXNPI 1730485418
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $513, 2.1 times the $244 reported in 2019. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$287
- Cranial Technologies, Inc$233
- Supernus Pharmaceuticals, Inc.$209
- Sanofi Pasteur Inc.$130
- Tris Pharma Inc$106
- Takeda Pharmaceuticals U.S.A., Inc.$96
- plus $664 from 17 others
What the payments were for
- Food & beverage$1,725100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 15 | $287 |
| Cranial Technologies, Inc | 16 | $233 |
| Supernus Pharmaceuticals, Inc. | 9 | $209 |
| Sanofi Pasteur Inc. | 6 | $130 |
| Tris Pharma Inc | 5 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $96 |
| Merck | 6 | $87 |
| Pfizer | 6 | $87 |
| Ironshore Pharmaceuticals Inc. | 4 | $71 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $67 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Shire North American Group Inc | 3 | $42 |
| Seqirus USA Inc | 2 | $32 |
| Sobi, Inc | 1 | $31 |
| Ultragenyx Pharmaceutical Inc. | 1 | $28 |
| Biogen | 1 | $22 |
| Kaleo, Inc. | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Aytu Biopharma, Inc. | 1 | $15 |
| Neos Therapeutics, LP | 1 | $14 |
| Novartis | 1 | $13 |
How this compares
$1,725 in reported general payments places this provider in the 90th percentile of 5,361 pediatrics providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ArexvyRsvpref3 Antigen/As01e/Pf | 95 | $31,212 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 15 | $3,464 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Houston
- Pedro PiedraHouston$729K
- Vernon SuttonHouston$90K
- Carlos BacinoHouston$53K
- Farida AbidHouston$50K
- Lindsay CameronHouston$32K
- Juan Torres SanchezHouston$31K
- Martin YudovichHouston$24K
- Raegan HuntHouston$23K
- Michael PickettHouston$14K
- Lara LeonhardtHouston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.